Company profile

Company profileOfficial Gazette noticesJapanese original

大幸薬品株式会社

大幸薬品株式会社· Corporate Number: 2120901007344

This page aggregates company identity, Official Gazette notices, enforcement records, related-company signals, and source-review links into one public-record profile.

Ask RegBase about this company

Current page: Company profile

This page brings together Official Gazette notices, enforcement records, registry data, related-company signals, and source-review links for one company. Open individual enforcement records from the history section below.

Public Record Summary

Gazette notices shown here
1
Latest public record
23 Apr 2024

Company Identity and Registry Data

English display name
大幸薬品株式会社
Original Japanese name
大幸薬品株式会社
Corporate Number
2120901007344
Registered address
大阪府吹田市内本町３丁目３４番１４号

Note: Detailed gBizINFO registry data may not be available for this company yet. Use the public registry links below to review supplemental source information.

View on gBizINFOView on the National Tax Agency Corporate Number site

gBizINFO: fetched 25 Apr 2026

Corporate Number site: fetched 22 Oct 2026

Data sources

Direct inquiry

Need a person to review 大幸薬品株式会社?

No account needed

Ask a Japan-based team member to confirm the legal entity, explain the recorded public sources, or scope a documented screening.

Inquiry context: 大幸薬品株式会社 / Corporate Number 2120901007344

No phone number or account is required. We normally reply within two to three business days. Read our privacy policy.

English public-record screening

Need a documented check for 大幸薬品株式会社?

Get a structured English summary of the company identity and public records collected by RegBase, with source links, confirmation dates, and a clearly stated scope.

  • ✓ English and Japanese company identity
  • ✓ Enforcement and public-record summary
  • ✓ Official-source URLs and confirmation dates
  • ✓ PDF or CSV for an internal review file

This is not a credit report, safety guarantee, sanctions conclusion, legal opinion, or full due-diligence investigation.

No account required. The report opens immediately after Stripe confirms payment.

See sample screeningView pricingAsk a Japan-based researcher

Public documents and saved materials

View the original publications, see what was preserved, or download each file below.

Loading materials…

Need help interpreting these materials or confirming which legal entity they belong to? Ask RegBase about this company.

Official Gazette

Japanese Official Gazette company notices

1 notice(s)

Official Gazette company notice

Capital reduction noticeCapital or reserve notice
Publication / issue / page
23 Apr 2024 Main Edition 第1208号 p.31
English summary
The Japanese Official Gazette published capital reduction notice for 大幸薬品株式会社. Notice of reduction of capital or reserves.
Published company name
大幸薬品株式会社
Published address
大阪府吹田市内本町三丁目三四番一四号
Claim period
Within 1 month(s) from the day after publication
Translated excerpt
Notice of reduction of capital or reserves
Source
Official Gazette
Show original Japanese extracted fields
Original notice type
資本金の額の減少公告
Original related text
資本金の額を二十二億八千七百七十一万六千八百八十円減少し一千万円とすることにいたしました
Original excerpt
資本金の額を二十二億八千七百七十一万六千八百八十円減少し一千万円とすることにいたしました
Show official Japanese notice text

第 １２０８ 号 令和６年４月２３日火曜日 官　報 （本　　紙） 公　　告 会社その他の公告資本金の額の減少公告 page="0031"　当社は、資本金の額を二十二億八千七百七十一万六千八百八十円減少し一千万円とすることにいたしました。　効力発生日は令和六年五月三十一日であり、株主総会の決議は、令和六年三月二十八日に終了しております。　この決定に対し異議のある債権者は、本公告掲載の翌日から一箇月以内にお申し出下さい。　なお、最終貸借対照表の開示状況は次のとおりです。　金融商品取引法による有価証券報告書提出済。　令和六年四月二十三日大阪府吹田市内本町三丁目三四番一四号大幸薬品株式会社　代表取締役　柴田　　高　©2010独立行政法人国立印刷局/National Printing Bureau. All rights reserved.

Language

日本語版を見る (Japanese)

About this English name

No official English name source is recorded. The original Japanese name is shown.

If this profile contains an error or your company needs to add context, please use the data correction request form. Submissions are reviewed under RegBase editorial policy.

This page mechanically aggregates and structures public government disclosures and public registry data under the methodology. It is not legal advice, credit scoring, or a final procurement decision. Always verify against the official source pages.